Current insights into the innate immune system dysfunction in irritable bowel syndrome

Area of Science:

• Immunology
• Gastroenterology
• Pathophysiology

Background:

• Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder characterized by abdominal pain and altered bowel habits, significantly impacting patient quality of life and imposing economic burdens.
• The exact pathogenesis of IBS remains unclear, hindering the development of effective pharmacological interventions and leading to slow drug development.
• Existing research suggests a role for low-grade inflammation and innate immune system dysfunction in IBS, though findings are often contradictory.

Purpose of the Study:

• To review and summarize current knowledge on the involvement of immunological alterations in the development of Irritable Bowel Syndrome (IBS).
• To highlight the potential role of immune cells, mediators, and receptors in IBS pathophysiology.
• To discuss the implications of immune dysregulation for IBS heterogeneity and treatment.

Main Methods:

• Literature review of existing studies on immunology and IBS.
• Analysis of evidence implicating immune cells (e.g., mast cells, eosinophils) and mediators in IBS.
• Examination of research on cytokine imbalance and Toll-like receptor (TLR) dysregulation in IBS patients.

Main Results:

• Substantial evidence supports innate immune system dysfunction in several IBS phenotypes.
• Key immune cells, their mediators, and cytokine imbalances appear significant in specific IBS subgroups.
• Dysregulation of Toll-like receptors has been reported in patients with IBS, suggesting a role in pathogen recognition and immune response.

Conclusions:

• Immunological alterations, particularly innate immune system dysfunction, are implicated in the development of IBS.
• The heterogeneity of IBS may be explained by multiple underlying causes leading to distinct disease phenotypes and variable study results.
• Additional research is crucial to elucidate the precise pathogenetic pathways involving immunological factors in IBS.